Clinical Diagnostics

The Providence Service Corporation Reports Third Quarter 2020 Financial Results | Business Wire | 11/6/2020

… Äôs in-home and telehealth comprehensive health assessments continued to ramp during the quarter. On October 2, 2020, Matrix announced the acquisition of Biocerna, a CLIA-certified and CAP-accredited laboratory dedicated to delivering clinical diagnostics tests to improve patients‚Äô safety and quality of care. Biocerna has developed innovative assays, including for COVID-19 testing, that will allow Matrix to provide safe and expedient testing services to Matrix’s clients …

LabRoots Unveils Full Agenda at its 11th Annual Clinical Diagnostics & Research Virtual Event, hosted on November 12, 2020 | PRWeb | 11/5/2020

LabRoots Unveils Full Agenda at its 11th Annual Clinical Diagnostics & Research Virtual Event, hosted on November 12, 2020 Share Article More than 15 presentations will be showcased to deliver firsthand insights into new and emerging diagnostic technologies evolving the field in healthcare and disease management settings Clincal Diagnostics & Research, November 12, 2020 YORBA LINDA, Calif. (PRWEB) November 05, 2020 LabRoots, the leading scientific social networking website offering premier, interactive virtual …

Follow Clinical Diagnostics:    

** | 11/2/2020**

… expected to witness the highest growth in the AST market, during the forecast period. Based on application, the antimicrobial susceptibility testing market has been segmented into the antimicrobial susceptibility testing market is segmented into clinical diagnostics , drug discovery and development, epidemiology, and other applications. The growth in this market is attributed to the rising prevalence of infectious diseases, increasing incidence of HAIs, large target patient population base (especially in emerging …

Validea’s Top Five Technology Stocks Based On David Dreman - 11-1-2020 | Nasdaq | 11/2/2020

… and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics . Life Science segment markets and develops, manufactures and markets approximately 6,000 reagents, apparatus and laboratory instruments. Its products are used in research techniques, biopharmaceutical production processes and food testing regimes. Clinical Diagnostics segment designs …

Bio-Rad (BIO) Q3 Earnings Surpass Estimates, Margins Rise - October 30, 2020 - Zacks.com | 10/30/2020

… driven by sales of Polymerase Chain Reaction (‚ÄúPCR‚Äù) and Droplet Digital PCR and Process Media products. Geographically, the company‚Äôs quarterly growth at CER was experienced by all regions. Net sales at the Clinical Diagnostics segment totaled $322.2 million, down 5.7% on a year-over-year basis and 5.9% at CER. The downside at CER was driven by lower demand due to the pandemic and was across most product …

Inspirata and Flagship Biosciences Announce New Technical Partnership and Integration at Pathology Visions 2020 | 10/27/2020

Tampa, Florida / Westminster, Colorado, Oct. 27, 2020 (GLOBE NEWSWIRE) — Cancer informatics and digital pathology provider Inspirata announced today a new technical partnership with clinical diagnostics service provider, Flagship Biosciences. The new partnership provides clinicians with digital access to TissueInsight™, an AI-based analysis engine for Send-Out tests like PD-L1. Working together, Flagship Bioscience’s TissueInsight and Inspirata’s Dynamyx solutions offer significant advantages over shipping physical samples. Inspirata’s Dynamyx affords …

Global Colorimetric Immunoassays (CI) Analyzer Market Insights and Forecast to 2026 | 10/26/2020

Check Discount COVID-19 Understand the influence of COVID-19 on the Colorimetric Immunoassays CI Analyzer Market with our analysts monitoring the situation across the globe. Request Now Colorimetric Immunoassays (CI) Analyzer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Colorimetric Immunoassays (CI) Analyzer market will be able to gain the upper hand as they use the report as a powerful resource …

Global Blood Screening Industry | Markets Insider | Business Insider | 10/24/2020

… is also addressed. Competitors identified in this market include, among others, Abbott Laboratories Beckman Coulter, Inc. Becton, Dickinson & Company bioMerieux SA Bio-Rad Laboratories, Inc. F. Hoffmann-La Roche AG Grifols International SA Ortho Clinical Diagnostics , Inc. Siemens Healthineers Thermo Fisher Scientific, Inc. Read the full report: https://www.reportlinker.com/p05798062/?utm_source=GNW I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY

  1. MARKET OVERVIEW Blood Screening Market to Witness Moderate …

Genetron Health Enters Exclusive Global Licensing Agreement with ImmuQuad Biotechnologies to Develop and Commercialize Minimal Residual Disease Assays in Hematologic Cancer | Globe Newswire | 10/22/2020

… product sales for 10 years following commercialization. Separately, Genetron Health has made a minority equity investment in ImmuQuad. ImmuQuad is a leading biotechnology company in China focused on developing an immune profiling platform for clinical diagnostics and life sciences research. The Company’s proprietary immunomics platform employs next-generation sequencing (NGS) technology to read and decode the diverse genetic code of a patient’s adaptive immune system and applies it in key …

Danaher Corp. (DHR) Q3 2020 Earnings Call Transcript | 10/22/2020

… one time, and we estimate that approximately 60% to 70% of academic research labs are now open in some capacity; and in China, that number is closer to pre-pandemic level. Moving to a clinical diagnostics . We continue to see strong demand from molecular testing in both hospital lab and point of care setting. Since launching the first rapid molecular test for COVID-19 in March, Cepheid has meaningfully increased …

Global Gonorrhea Diagnostic Market Research Report 2020-2024 | 10/21/2020

… forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The major players profiled in this report include: Abott Roche Tosoh Siemens bioMrieux PerkinElmer Ortho Clinical Diagnostics …… The end users/applications and product categories analysis: On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split …

Aiforia Announces Formation of Scientific Advisory Board | 10/21/2020

… a leading provider of deep learning artificial intelligence (AI) solutions for image analysis across a variety of medical domains, announces its newly formed Scientific Advisory Board. The four advisors represent world-class expertise in clinical diagnostics , personalized medicine, digital and computational pathology. The Scientific Advisory Board will support Aiforia’s mission in providing the most powerful tools for AI-assisted analysis to enhance the translation of medical images into data and …

Advanced Manufacturing: Manufacturing Muscle Joins The Fight | 10/21/2020

… complex challenges. Greater Rochester, NY includes 120 companies in optics, photonics and imaging; more than 250 companies in food and beverage manufacturing; and global leaders in life sciences such as Bausch and Lomb, Ortho Clinical Diagnostics , CooperVision and Thermo Fisher Scientific. Anchored by 19 colleges and universities, Greater Rochester, NY leads the U.S. among large metros for degrees in STEM programs such as physical sciences and mathematics. In total, the …

Inmedix Inc. gets listed on THE OCMX™ - Limited priced-round opportunity that closes October 31, 2020 | 10/21/2020

… and low margins of traditional clinical laboratories and launching with the first accurate clinical measure of stress. Think bloodless LabCorp or Quest Diagnostics in the Microsoft Azure cloud. Applying the cloud, Inmedix identified actionable clinical diagnostics from bloodless biomarkers (ECG, EEG, facial recognition, etc.) We begin by bringing the 5-min ECG stress testing trusted by professional sports and US Special Forces through the FDA to clinicians. The OCMX™ is …

Inmedix Inc. gets listed on THE OCMX™ – Limited priced-round opportunity that closes October 31, 2020 | 10/21/2020

… and low margins of traditional clinical laboratories and launching with the first accurate clinical measure of stress. Think bloodless LabCorp or Quest Diagnostics in the Microsoft Azure cloud. Applying the cloud, Inmedix identified actionable clinical diagnostics from bloodless biomarkers (ECG, EEG, facial recognition, etc.) We begin by bringing the 5-min ECG stress testing trusted by professional sports and US Special Forces through the FDA to clinicians. The OCMX™ is …

Eurofins U.S. Clinical Diagnostics Network Receives EUA Approval of At Home COVID-19 Test | Business Wire | 10/19/2020

LUXEMBOURG- Regulatory News: Eurofins U.S. Clinical Diagnostics (Paris:ERF), announced that Clinical Enterprise Inc. has received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for their At Home COVID-19 Nasal PCR Test. The EUA authorized self-collection kit gives consumers a minimally invasive, convenient and quick option to test from the comfort of their home. Results are reviewed by a licensed physician and provided …

Eurofins U.S. Clinical Diagnostics Network Receives EUA Approval of At Home COVID-19 Test | Business Wire | 10/19/2020

LUXEMBOURG- Eurofins U.S. Clinical Diagnostics , announced that Clinical Enterprise Inc. has received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for their at Home COVID-19 Nasal PCR Test. The EUA authorized self-collection kit gives consumers a minimally invasive, convenient and quick option to test from the comfort of their home. Results are provided via email within 24 hours of sample receipt. Available through …

Eurofins U.S. Clinical Diagnostics Network Receives EUA Approval of At Home COVID-19 Test | Markets Insider | Business Insider | 10/19/2020

Eurofins U.S. Clinical Diagnostics, announced that Clinical Enterprise Inc. has received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for their at Home COVID-19 Nasal PCR Test. The EUA authorized self-collection kit gives consumers a minimally invasive, convenient and quick option to test from the comfort of their home. Results are provided via email within 24 hours of sample receipt. Available through the …

Future Prospects of Blood Screening Market to Witness Robust Expansion by 2026 with Top Key Players like Grifols, F. Hoffmann-La Roche, Abbott Laboratories, Biomerieux, Bio-Rad Laboratories | 10/19/2020

… by considering the impact of COVID-19. Top Key Players Profiled in this report are: Grifols, F. Hoffmann-La Roche, Abbott Laboratories, Biomerieux, Bio-Rad Laboratories, Siemens Healthineers (A Subsidiary Of Siemens Ag), Ortho Clinical Diagnostics , Thermo Fisher Scientific, Beckman Coulter (A Subsidiary Of Danaher Corporati, Bd. The key questions answered in this report: What will be the Market Size and Growth Rate in the forecast year? What are the …

Eurofins U.S. Clinical Diagnostics Network Receives EUA Approval of At Home COVID-19 Test | Yahoo News | 10/19/2020

At Home COVID-19 Nasal PCR Test is easy to use and painless Eurofins U.S. Clinical Diagnostics , announced that Clinical Enterprise Inc. has received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for their at Home COVID-19 Nasal PCR Test. The EUA authorized self-collection kit gives consumers a minimally invasive, convenient and quick option to test from the comfort of their home. Results …

Immuno Oncology Assays Market: Increasing Adoption of Targeted Therapy and mAbs. | 10/16/2020

… 2020. Submitted by Andrew . According to the new market research report “ Immuno Oncology Assays Market by Product (Consumables, Software), Technology (Immunoassay, Flow Cytometry, PCR, Next Generation Sequencing), Indication (Lung Cancer, Colorectal Cancer), Application (Research, Clinical Diagnostics ) - Global Forecast to 2024 “, published by MarketsandMarkets™, the market for Immuno-Oncology Assays is expected to grow from USD 2.9 billion in 2018 to USD 5.9 billion by 2024, at a CAGR of 12.7 …

Crwe World | Lab Automation Market to Reach $5.20 Billion by 2022 with High Demand for Lab Automation Equipment in Drug Discovery | 10/15/2020

2 Views ( EMAILWIRE.COM , October 15, 2020 ) According to a new market research report “ Lab Automation Market by Equipment and Software (Robotic Arms, Microplate Readers, LIMS), Applications (Drug Discovery, Clinical Diagnostics , Genomics), End Users (Biotechnology and Pharmaceuticals, Diagnostic Labs) - Global Forecast to 2022”, published by MarketsandMarkets, the market is expected to reach USD 5.20 Billion by 2022 from an estimated USD 4.06 Billion in 2017, at a CAGR of 5.1%. Browse …

UMass Inclusive Excellence Initiative Continues for Third Year | 10/15/2020

… Internet & Online // 0 Comments Pune, India, 2020-Oct-15 — /EPR Network/ — According to a new market research report “ Microplate Systems Market, by Product (Microplate Reader (Multi-mode (Hybrid), Single-mode), Dispenser, Software), Application (Research, Clinical Diagnostics ) & End User (Biotechnology, Pharmaceutical, Hospital, Diagnostic Labs) – Forecast to 2022 “, the global market is expected to reach USD 996.9 million by 2022 from USD 820.3 million in 2017, at a CAGR of 4.0%. Browse …

Beckman Coulter receives BARDA funding to validate Monocyte Distribution Width in the rapid detection of Multisystem Inflammatory Syndrome (MIS-C), a severe COVID-19 complication in Children | PR Newswire | 10/15/2020

BREA, Calif. , Oct. 15, Beckman Coulter, a global clinical diagnostics leader, today announced that it was awarded funding by the Biomedical Advanced Research and Development Authority ( BARDA ) part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, for a multi-center clinical trial to validate the ability of its Monocyte Distribution Width (MDW) hematology biomarker to aid in the …

HTG Molecular Diagnostics Inc. [HTGM] Is Still Undervalued at $0.32 | 10/15/2020

PARIS & CAMBERLEY, England–( BUSINESS WIRE )–Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics , announces the acquisition of the entire share capital of IT-IS International Ltd (IT-IS), a profitable diagnostic instrument development and manufacturing company, for an initial cash consideration of £10.1 million. IT-IS is the exclusive manufacturer of Novacyt’s q16 and q32 rapid polymerase chain reaction (PCR) instruments. Highlights Reinforces new …

Patient Safety

LabRoots Unveils Full Agenda at its 11th Annual Clinical Diagnostics & Research Virtual Event, hosted on November 12, 2020 | PRWeb | 11/5/2020

LabRoots Unveils Full Agenda at its 11th Annual Clinical Diagnostics & Research Virtual Event, hosted on November 12, 2020 Share Article More than 15 presentations will be showcased to deliver firsthand insights into new and emerging … data, considerations for specific patient populations, and laboratory stewardship and patient safety, to complete the day. The program kicks off with a presentation sponsored by Visiopharm on standardization with clinical digital pathology ‚Äì the Ki …

Companion Diagnostics

Genetron Health Enters Exclusive Global Licensing Agreement with ImmuQuad Biotechnologies to Develop and Commercialize Minimal Residual Disease Assays in Hematologic Cancer | Globe Newswire | 10/22/2020

… GTH), a leading precision oncology company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that it has entered an exclusive licensing agreement with Hangzhou … in China focused on developing an immune profiling platform for clinical diagnostics and life sciences research. The Company’s proprietary immunomics platform employs next-generation sequencing (NGS) technology to read and decode the diverse genetic code …

Food and Drug Administration

Eurofins U.S. Clinical Diagnostics Network Receives EUA Approval of At Home COVID-19 Test | Business Wire | 10/19/2020

LUXEMBOURG- Regulatory News: Eurofins U.S. Clinical Diagnostics (Paris:ERF), announced that Clinical Enterprise Inc. has received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for their At Home COVID-19 Nasal PCR Test. The EUA authorized self-collection kit gives consumers a minimally invasive, convenient and quick option to test from the comfort of their home. Results are reviewed by a licensed physician and provided …

COVID-19

Eurofins U.S. Clinical Diagnostics Network Receives EUA Approval of At Home COVID-19 Test | Business Wire | 10/19/2020

LUXEMBOURG- Regulatory News: Eurofins U.S. Clinical Diagnostics (Paris:ERF), announced that Clinical Enterprise Inc. has received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for their At Home COVID-19 Nasal PCR Test. The EUA authorized self-collection kit gives consumers a minimally invasive, convenient and quick option to test from the comfort of their home. Results are reviewed by a licensed physician and provided …

CDC

Beckman Coulter receives BARDA funding to validate Monocyte Distribution Width in the rapid detection of Multisystem Inflammatory Syndrome (MIS-C), a severe COVID-19 complication in Children | PR Newswire | 10/15/2020

BREA, Calif. , Oct. 15, Beckman Coulter, a global clinical diagnostics leader, today announced that it was awarded funding by the Biomedical Advanced Research and Development Authority ( BARDA ) part of the office of the Assistant Secretary … Recently defined by the Centers for Disease Control and Prevention (CDC), MIS-C is a rare but severe complication seen in children following SARS-CoV-2 infection. Beckman Coulter receives BARDA funding to validate Monocyte …

Diagnostic Tests

Ortho Awarded BARDA Contract to Accelerate Antigen Test Development and Additional SARS-CoV-2 Antibody Test Milestones | PR Newswire | 9/21/2020

RARITAN, N.J. Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced its continued collaboration with the Biomedical Advanced Research and Development Authority ( BARDA ), part of the Office of the Assistant Secretary for … exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless …

Department of Health and Human Services

Ortho Awarded BARDA Contract to Accelerate Antigen Test Development and Additional SARS-CoV-2 Antibody Test Milestones | PR Newswire | 9/21/2020

RARITAN, N.J. , Sept. 21, Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced its continued collaboration with the Biomedical Advanced Research and Development Authority ( BARDA ), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, in a new contract as part of BARDA’s and the federal government’s ongoing COVID-19 medical countermeasure development efforts. BARDA awarded …

Respiratory Care

Global Medical Device Industry Statistics Show Production Of Non-COVID Equipment Is Severely Impacted | Globe Newswire | 9/16/2020

respiratory care equipment and clinical diagnostics has grown positively in the pandemic. Therefore, the demand for COVID-19 medical equipment has grown tremendously due to their heavy usage and conversion of many hospitals for COVID treatment. Some other positively impacted medical equipment segments are in-vitro diagnostics, diagnostic imaging, and respiratory care equipment. The Business Research Company ’s report titled Medical Devices Market - Opportunities And Strategies – Global Forecast To 2030 …

ACA

Readers and Tweeters Grapple With COVID Therapies and Forecasts | Kaiser Health News | 9/14/2020

… Clinical Diagnostics, Raritan, New Jersey /em /p blockquote p I’m quoted here saying what everybody already knows: if we want to know if plasma works, we need a trial. /p p This isn’t academic for me: I want to know if I should be using plasma in my patients with severe COVID-19. This fiasco was preventable. a href=”https://t.co/MjS2DXbYUX” https://t.co/MjS2DXbYUX /a /p p — Adam W …

NIH

Readers and Tweeters Grapple With COVID Therapies and Forecasts | Kaiser Health News | 9/14/2020

… em Dr. Fernando Chaves, a board-certified hematopathologist who serves as Global Head of Medical and Scientific Affairs at Ortho Clinical Diagnostics, Raritan, New Jersey /em /p blockquote p I’m quoted here saying what everybody … regret that you said so little about a href=”https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467112/” therapies that may emerge /a to help us. Vaccines are not the only hope. I think a disservice is being done …

Medicaid

Readers and Tweeters Grapple With COVID Therapies and Forecasts | Kaiser Health News | 9/14/2020

… em Dr. Fernando Chaves, a board-certified hematopathologist who serves as Global Head of Medical and Scientific Affairs at Ortho Clinical Diagnostics, Raritan, New Jersey /em /p blockquote p I’m quoted here saying what everybody … point. The article has been updated. /em /p p strong Medicaid Expansion in the Age of COVID /strong /p p The COVID-19 pandemic has shown us that Americans are in desperate need of health …

Medical Research

Readers and Tweeters Grapple With COVID Therapies and Forecasts | Kaiser Health News | 9/14/2020

… em Dr. Fernando Chaves, a board-certified hematopathologist who serves as Global Head of Medical and Scientific Affairs at Ortho Clinical Diagnostics, Raritan, New Jersey /em /p blockquote p I’m quoted here saying what everybody … a sound idea. What good are medicine and doctors and medical research? Seems we should consider those old grandma medications, such as the hot toddy … whiskey and hot coffee and a good night to sweat …

AdvaMed

Diagnostic Makers: We’ve Shipped 145 Million Covid-19 Tests In U.S. Since March | Forbes | 9/11/2020

… makers have shipped 145 million molecular tests for the Coronavirus strain Covid-19 since March, the Advanced Medical Technology Association (AdvaMed) said Friday during its annual Medtech conference. AdvaMed and member diagnostic test makers, which … Becton Dickinson, bioMérieux, Bio-Rad, Beckman Coulter, Cepheid, Hologic, Ortho Clinical Diagnostics, Qiagen, Roche Diagnostics, Sekisui Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Less than two months ago when the registry launched , the companies involved …

Genomics

Eurofins U.S. Clinical Diagnostics Network Announces Launch Of Highly Accurate, Cost Effective, COVID-19 Pooled PCR Test | PR Newswire | 7/29/2020

Eurofins U.S. Clinical Diagnostics Network Announces Launch Of Highly Accurate, Cost Effective, COVID-19 Pooled PCR Test News provided by Jul 29, 2020, 16:02 ET Share this article (PRNewsfoto/Eurofins U.S. Clinical Diagnost) LEE’S SUMMIT … independent market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, CDMO, advanced material sciences and in the support of clinical studies. In addition, Eurofins is one of the leading global emerging …

Biotech

Global Respiratory Syncytial Virus Diagnostics Market 2020-2024 | Evolving Opportunities with Abbott Laboratories and Becton, Dickinson and Co. | Technavio | Business Wire | 6/26/2020

… offering RSV diagnosis test kits for testing COVID-19. For instance, the US FDA recently approved the use of Mesa Biotech’s Accula device for COVID-19 which gives results in about 30 minutes. The use … operates its business through segments such as Life Science and Clinical Diagnostics. The company offers Mouse anti Respiratory Syncytial Virus Fusion Protein that recognizes virus antigen and it is validated for ELISA, Immunofluorescence, and Immunohistochemistry …

Patient Management

BARDA and Ortho Collaborate to Advance Development of High Specificity SARS-CoV-2 Antibody Tests | PR Newswire | 6/17/2020

RARITAN, N.J. Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced it is collaborating with Biomedical Advanced Research and Development Authority ( BARDA ), a component of the Office of the Assistant Secretary for … recovery. The tests offer greater choice in tracking, surveillance and patient management. As noted on the U.S. Food and Drug Administration’s website, test results also can help aid in determining who may be eligible to …

Medicare

Webinar: Utilizing Regional Testing Capacity to fight COVID-19 | Modern Healthcare | 5/6/2020

… a highly distinguished record in public service and academic research, Dr. McClellan is a former administrator of the Centers for Medicare & Medicaid Services and former commissioner of the U.S. Food and Drug Administration (FDA), where … Gary was previously the CEO of LabCorp Diagnostics, a $7B clinical diagnostics organization. Before becoming CEO, Huff served as the senior vice president of health systems and strategic alliances for LabCorp Diagnostics. Before joining LabCorp …

National Institutes of Health

FDA, CDC, NIH to begin validating COVID-19 antibody tests as more enter the market | FierceBiotech | 4/20/2020

… with the Centers for Disease Control and Prevention as well as the infectious disease and cancer research arms of the National Institutes of Health (NIH) to help generate validation data and make sure blood tests … products include an automated, high-throughput test manufactured by Ortho Clinical Diagnostics for its Vitros system; a rapid, point-of-care, fingerstick blood test by ChemBio Diagnostics ; and a highly sensitive enzyme-linked immunosorbent assay …

National Cancer Institute

Dozens of coronavirus antibody tests on the market were never vetted by the FDA, leading to accuracy concerns | Chicago Tribune | 4/19/2020

… at all.” Prodded by such concerns, the FDA recently has stepped up warnings and is joining other agencies, including the National Cancer Institute, to try to determine whether the unvetted tests actually work. The Inquirer … tests have gotten such authorizations: Cellex, Chembio Diagnostic Systems, Ortho Clinical Diagnostics and Mount Sinai Laboratory. » READ MORE: Coronavirus blood test to look for immunity gets a tryout in Chester County The new validation of …

Blood Screening

Blood Screening Market to Rise at 7.4% CAGR till 2026 Driven by the Increasing Number of Regulatory Clearances for New Tests, says Fortune Business Insights™ | Globe Newswire | 4/3/2020

Key Companies Covered in the Blood Screening Market Research Report are Bio-Rad Laboratories, Inc., Grifols, S.A., F. Hoffmann-La Roche, Ortho Clinical Diagnostics, BD, DiaSorin S.p.A., Thermo Fisher Scientific Inc., Abbott, QUOTIENT, Other Players April 03, 2020 10:45 ET Source: Fortune Business Insights Pune, April 03, The global blood screening market size is projected to reach USD 4.09 billion by the end of 2026. The increasing awareness regarding blood …

Health Research

Global C-Reactive Protein Testing Market Expected to Grow with a CAGR of 1.3% During the Forecast Period, 2020-2027 - ResearchAndMarkets.com | Business & Finance | heraldchronicle.com | Business Wire | 3/13/2020

… for research entities that are engaged in performing research activities in this area, boost market progression. The National Institute for Health Research, the Wellcome Trust, and the Department for International Development are among the few … reinforce their market presence For instance, in May 2018, Ortho Clinical Diagnostics signed an agreement with Sentinel Diagnostics to develop CRP Ultra (MP) Assay for future CRP testing in hospitals and laboratories. Key Topics Covered …

Oncology Diagnostics

Viracor Eurofins Expands Its Clinical Diagnostic Footprint to Oncology | Yahoo News | 12/11/2019

Viracor Eurofins (Viracor), proudly announces the addition of span class=”xn-person” Karina Eterovic /span , PhD, as the Director of Research & Development for Oncology Diagnostics for Eurofins U.S. Clinical Diagnostics group. Dr. Eterovic will lead the development and growth of oncology clinical diagnostic solutions to benefit our healthcare clients and their patients.” data-reactid=”12” LEE’S SUMMIT, Mo. , Dec. 11, 2019 /PRNewswire/ – Viracor Eurofins (Viracor), proudly announces the addition of …

Precision Medicine

Analysis on the World Market for Biomarkers 2016-2019 & 2025: Key Trends, Discovery Techniques & Applications | Globe Newswire | 12/4/2019

… NEO Systems by Bruker NanoString Collaborated with National Cancer Institute to Improve Cancer Immunotherapy Biomarker Discovery Thermo Fisher Scientific Opens Precision Medicine Science Center in The United States Myriad Genetics to Acquire Counsyl Thermo Fisher … Illumina and Extends the Application of MiSeqTM Dx System Ortho Clinical Diagnostics to Use EKF Diagnostics’ Diabetic Ketoacidosis Assay Thermo Fisher Scientific and Blueprint Medicines Ink Deal for Oncology Companion Diagnostic Development Expansion of laboratory …

Cancer Therapy

Global Polymerase Chain Reaction (PCR) Market 2019-2025: Increasing Demand for PCR in Genetic and Molecular Testing | PR Newswire | 12/4/2019

… technological advancements and growing demand for rapid diagnostic tests. However, factors like the high cost of commercial PCR assays in clinical diagnostics, lack of awareness and requirement of skilled labor, development of alternate technologies and … and others. Non-infectious diseases include prenatal diagnosis, tissue typing, cancer therapy, genetic typing for hereditary disease, blood screening, and others. Industrial applications are divided into Agricultural, Environment, Applied testing, Animal husbandry, biomedical research, and …

Regenerative Medicine

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

… Blood Center Boryung Pharmaceutical Bristol-Myers Squibb Bristol-Myers Squibb Foundation C-Bridge Capital Cadila Pharmaceuticals Calbiotech California Institute for Regenerative Medicine Calithera Biosciences Capnia Cardiome Pharma Casebia Therapeutics Case Western Reserve University Catalyst Biosciences … Novartis NovImmune Novo Nordisk Nxstage Medical Octapharma OMRF OrSense Ortho-Clinical Diagnostics Otsuka Oxford BioMedica Palex Medical Pan American Cancer Treatment Centers PathoQuest Pathway Diagnostics PBM Capital Group Peking University Pfenex Pfizer Pfizer Japan Pharmacosmos …

Grifols

Blood Group Typing Market Worth $2.68 Billion at 7.2% CAGR by 2027; Dominant Players Such as Grifols and Merck Focus on Developing Advanced Blood Typing Solutions: Fortune Business Insights™ | Globe Newswire | 9/29/2020

Key Companies Covered in the Blood Group Typing Market Research Report Are Agena Bioscience, Beckman Coulter, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Ortho Clinical Diagnostics, Immucor, Inc., QUOTIENT, Grifols, S.A. and other key market players. September 29, 2020 10:51 ET Source: Fortune Business Insights Pune, Sept. 29, 2020 (GLOBE NEWSWIRE) – The global blood group typing market size is projected to reach USD 2.68 billion by 2027, exhibiting a CAGR …

Siemens

Global Serological Transplant Diagnostics Industry | Globe Newswire | 9/23/2020

Clinical Diagnostics Quotient Biodiagnostics REAGENS Kft. Siemens Healthineers Thermo Fisher Scientific, Inc. Tulip Ltd. Read the full report: https://www.reportlinker.com/p05960007/?utm_source=GNW I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Global Competitor Market Shares Serological Transplant Diagnostics Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL …

Siemens Healthineers

Global Serological Transplant Diagnostics Industry | Globe Newswire | 9/23/2020

Clinical Diagnostics Quotient Biodiagnostics REAGENS Kft. Siemens Healthineers Thermo Fisher Scientific, Inc. Tulip Ltd. Read the full report: https://www.reportlinker.com/p05960007/?utm_source=GNW I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Global Competitor Market Shares Serological Transplant Diagnostics Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL …

Qiagen

Global Transplantation Industry | Globe Newswire | 9/22/2020

Clinical Diagnostics Oxford Immunotec Global PLC Pacific Biosciences of California, Inc. Pandorum Technologies Pvt. Ltd. Qiagen NV Siemens Healthineers SynCardia Thermo Fisher Scientific, Inc. Transplant Biomedicals S.L. XVIVO Perfusion AB Read the full report: https://www.reportlinker.com/p05960330/?utm_source=GNW I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Global Competitor Market Shares Transplantation Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of Covid-19 and a …

Abbott Laboratories

Global Transplantation Industry | Globe Newswire | 9/22/2020

… Abbott Laboratories, Inc. Acelity LP, Inc. Avioq, Inc. AxoGen, Inc. BD Biosciences BioLife Solutions Inc. Bio-Rad Laboratories, Inc. CareDx, Inc. Carmat SA Chronix Biomedical Dr. Franz Kohler Chemie GmbH F. Hoffmann-La Roche AG GenDx Histogenics Corporation Illumina, Inc. Luminex Corporation Medipex Limited Miromatrix Medical Inc. Nano Dimension Ltd. Organovo Holdings, Inc. Ortho Clinical Diagnostics Oxford Immunotec Global PLC Pacific Biosciences of California, Inc. Pandorum Technologies Pvt. Ltd. Qiagen …

Thermo Fisher

Global Transplantation Industry | Globe Newswire | 9/22/2020

Clinical Diagnostics Oxford Immunotec Global PLC Pacific Biosciences of California, Inc. Pandorum Technologies Pvt. Ltd. Qiagen NV Siemens Healthineers SynCardia Thermo Fisher Scientific, Inc. Transplant Biomedicals S.L. XVIVO Perfusion AB Read the full report: https://www.reportlinker.com/p05960330/?utm_source=GNW I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Global Competitor Market Shares Transplantation Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of Covid-19 and a …

Luminex

Global Transplantation Industry | Globe Newswire | 9/22/2020

Luminex Corporation Medipex Limited Miromatrix Medical Inc. Nano Dimension Ltd. Organovo Holdings, Inc. Ortho Clinical Diagnostics Oxford Immunotec Global PLC Pacific Biosciences of California, Inc. Pandorum Technologies Pvt. Ltd. Qiagen NV Siemens Healthineers SynCardia Thermo Fisher Scientific, Inc. Transplant Biomedicals S.L. XVIVO Perfusion AB Read the full report: https://www.reportlinker.com/p05960330/?utm_source=GNW I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Global Competitor Market Shares Transplantation …

CareDx

Global Transplantation Industry | Globe Newswire | 9/22/2020

… CareDx, Inc. Carmat SA Chronix Biomedical Dr. Franz Kohler Chemie GmbH F. Hoffmann-La Roche AG GenDx Histogenics Corporation Illumina, Inc. Luminex Corporation Medipex Limited Miromatrix Medical Inc. Nano Dimension Ltd. Organovo Holdings, Inc. Ortho Clinical Diagnostics Oxford Immunotec Global PLC Pacific Biosciences of California, Inc. Pandorum Technologies Pvt. Ltd. Qiagen NV Siemens Healthineers SynCardia Thermo Fisher Scientific, Inc. Transplant Biomedicals S.L. XVIVO Perfusion AB Read the full report: https …

Thermo Fisher Scientific

Global Transplantation Industry | Globe Newswire | 9/22/2020

Clinical Diagnostics Oxford Immunotec Global PLC Pacific Biosciences of California, Inc. Pandorum Technologies Pvt. Ltd. Qiagen NV Siemens Healthineers SynCardia Thermo Fisher Scientific, Inc. Transplant Biomedicals S.L. XVIVO Perfusion AB Read the full report: https://www.reportlinker.com/p05960330/?utm_source=GNW I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Global Competitor Market Shares Transplantation Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of Covid-19 and a …

Illumina

Global Transplantation Industry | Globe Newswire | 9/22/2020

… Illumina, Inc. Luminex Corporation Medipex Limited Miromatrix Medical Inc. Nano Dimension Ltd. Organovo Holdings, Inc. Ortho Clinical Diagnostics Oxford Immunotec Global PLC Pacific Biosciences of California, Inc. Pandorum Technologies Pvt. Ltd. Qiagen NV Siemens Healthineers SynCardia Thermo Fisher Scientific, Inc. Transplant Biomedicals S.L. XVIVO Perfusion AB Read the full report: https://www.reportlinker.com/p05960330/?utm_source=GNW I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Global Competitor Market …

Bio-Rad Laboratories

Global Transplantation Industry | Globe Newswire | 9/22/2020

… Bio-Rad Laboratories, Inc. CareDx, Inc. Carmat SA Chronix Biomedical Dr. Franz Kohler Chemie GmbH F. Hoffmann-La Roche AG GenDx Histogenics Corporation Illumina, Inc. Luminex Corporation Medipex Limited Miromatrix Medical Inc. Nano Dimension Ltd. Organovo Holdings, Inc. Ortho Clinical Diagnostics Oxford Immunotec Global PLC Pacific Biosciences of California, Inc. Pandorum Technologies Pvt. Ltd. Qiagen NV Siemens Healthineers SynCardia Thermo Fisher Scientific, Inc. Transplant Biomedicals S.L. XVIVO Perfusion AB Read …

Roche Diagnostics

Global Automated Immunoassay Analyzers Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread) | 9/21/2020

Clinical Diagnostics Abbott Luminex Corporation Becton Dickinson and Company BioMerieux Inova DX Aesku Diagnotics Siemens Healthcare BioRad Roche Diagnostics Perkin Elmer Diasorin Arlington Scientific In Chapter 11 and 13.3, on the basis of types, the Automated Immunoassay Analyzers market from 2015 to 2026 is primarily split into: Immunofluorescence Chemiluminescence ELISA Enzyme Linked Fluorescent System Multiplexed Assay System Radioimmunoassay In Chapter 12 and 13.4, on the basis of applications, the Automated …

Merck

Global Diagnostic Lab Testing Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread) | 9/16/2020

… covered in Chapter 4: University Hospital Zurich Bipea UNILABS Waters Corporation Bio-Rad Laboratories Swiss TPH College of American Pathologists Merck Weqas Advanced Analytical Solutions, LLC QACS Randox Laboratories FAPAS Bioanalytica AG LGC Limited Swiss … Lab Testing market from 2015 to 2026 covers: Pharmaceuticals Biologics Clinical Diagnostics Microbiology Others Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are …

Medtronic

Global Medical Device Industry Statistics Show Production Of Non-COVID Equipment Is Severely Impacted | Globe Newswire | 9/16/2020

LONDON, (Medical Devices Companies Included: Medtronic Plc, Johnson & Johnson, Abbott Laboratories, Becton, Dickinson and Company, Siemens Healthineers AG) The evident shortage of required raw materials/components for the production of medical equipment has resulted in … On the contrary, the demand for respiratory care equipment and clinical diagnostics has grown positively in the pandemic. Therefore, the demand for COVID-19 medical equipment has grown tremendously due to their heavy usage and …

Johnson & Johnson

Global Medical Device Industry Statistics Show Production Of Non-COVID Equipment Is Severely Impacted | Globe Newswire | 9/16/2020

LONDON, (Medical Devices Companies Included: Medtronic Plc, Johnson & Johnson, Abbott Laboratories, Becton, Dickinson and Company, Siemens Healthineers AG) The evident shortage of required raw materials/components for the production of medical equipment has resulted in … On the contrary, the demand for respiratory care equipment and clinical diagnostics has grown positively in the pandemic. Therefore, the demand for COVID-19 medical equipment has grown tremendously due to their heavy usage and …

Regeneron Pharmaceuticals

Regeneron and University of Lausanne Publish Newomics M3 Emitters - Business Wire | 9/15/2020

… products and services, today announced that its award-winning multinozzle emitters ( Newomics® M3 emitters ) were featured in two publications from Regeneron Pharmaceuticals Inc. and the University of Lausanne , respectively. “Versatile, Sensitive, and Robust Native LC … these cases, for antibody-based drug development and blood-based clinical diagnostics, respectively. We look forward to further optimizing our products and services to best meet the diverse needs from our customers,” said Dr. Daojing …

Haemonetics

Global Blood Banking and Blood Products Industry | Globe Newswire | 9/7/2020

Haemonetics Corporation Immucor Inc. Kawasumi Laboratories, Inc. Kedrion S.p.A. LFB Group MacoPharma SA New York Blood Center Octapharma AG Ortho-Clinical Diagnostics, Inc. Shanghai RAAS Blood Products Co., Ltd. Shire plc Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Terumo BCT Inc. Read the full report: https://www.reportlinker.com/p05442546/?utm_source=GNW I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Blood Transfusion Worldwide: A Kaleidoscope of Stark Contrasts Recent …

Becton, Dickinson and Company

Global Blood Banking and Blood Products Industry | Globe Newswire | 9/7/2020

Becton, Dickinson and Company Beijing Tiantan Biological Products Co., Ltd. Bharat Serums and Vaccines Ltd. Bio Products Laboratory Ltd. bioMérieux SA Bio-Rad Laboratories, Inc. Biotest AG Canadian Blood Services Cerus Corporation China Biologic Products, Inc. CSL Behring LLC Fenwal Inc. Fresenius Kabi AG Grifols S.A. Haemonetics Corporation Immucor Inc. Kawasumi Laboratories, Inc. Kedrion S.p.A. LFB Group MacoPharma SA New York Blood Center Octapharma AG Ortho-Clinical Diagnostics, Inc. Shanghai …

Terumo

Global Blood Banking and Blood Products Industry | Globe Newswire | 9/7/2020

… Clinical Diagnostics, Inc. Shanghai RAAS Blood Products Co., Ltd. Shire plc Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Terumo BCT Inc. Read the full report: https://www.reportlinker.com/p05442546/?utm_source=GNW I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Blood Transfusion Worldwide: A Kaleidoscope of Stark Contrasts Recent Market Activity Safety and Availability: The Core Issues Current and Future Analysis World Blood Components and Plasma Market Analysis Red …

Bio-Techne

Global Biotechnology Reagents Industry | Globe Newswire | 9/5/2020

Bio-Techne Coporation Danaher Corporation F. Hoffmann-La Roche AG Fitzgerald Industries International General Electric Company Hoefer, Inc. Lonza Group Ltd. Merck KGaA Meridian Bioscience, Inc. Olympus Corporation Ortho Clinical Diagnostics PerkinElmer, Inc. Promega Corporation Quality Biological, Inc. Siemens Healthineers Sysmex Corporation Takara Holdings, Inc. Thermo Fisher Scientific, Inc. Tosoh Europe N.V. W. R. Grace & Co. Waters Corporation Read the full report: https://www.reportlinker.com/p05817889/?utm_source=GNW I. INTRODUCTION …

Danaher Corporation

Global Biotechnology Reagents Industry | Globe Newswire | 9/5/2020

Danaher Corporation F. Hoffmann-La Roche AG Fitzgerald Industries International General Electric Company Hoefer, Inc. Lonza Group Ltd. Merck KGaA Meridian Bioscience, Inc. Olympus Corporation Ortho Clinical Diagnostics PerkinElmer, Inc. Promega Corporation Quality Biological, Inc. Siemens Healthineers Sysmex Corporation Takara Holdings, Inc. Thermo Fisher Scientific, Inc. Tosoh Europe N.V. W. R. Grace & Co. Waters Corporation Read the full report: https://www.reportlinker.com/p05817889/?utm_source=GNW I. INTRODUCTION, METHODOLOGY & REPORT SCOPE …

Quest Diagnostics

Bio-Rad (BIO) Banks on Coronavirus PCR Tests Amid Cost Woes - July 9, 2020 - Zacks.com | 7/9/2020

… is a concern. The stock currently carries a Zacks Rank 3 (Hold). This California-based manufacturer and global supplier of clinical diagnostics and life-science research products has been outperforming its industry for the past … Some better-ranked stocks from the broader medical space are Quest Diagnostics Incorporated ( DGX - Free Report ) , Abbott Laboratories ( ABT - Free Report ) and QIAGEN N.V. ( QGEN - Free Report ) . Quest Diagnostics’ long-term earnings growth rate is …

GSK

Global Market Outlook for the Coronavirus Diagnostics Market to 2027 | PR Newswire | 6/19/2020

GSK Biologicals, Hologic, Lonza, Ortho-Clinical Diagnostics, PerkinElmer, Qiagen and Roche Diagnostics. What the report offers: Market share assessments for the regional and country-level segments Strategic recommendations for the new entrants Covers Market data for the years 2017, 2018, 2019, 2023 and 2027 Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) Strategic recommendations in key business segments based on the market estimations Competitive landscaping mapping the …

Biodesix

World Immuno-Oncology Diagnostics Market Forecasts to 2024 and the Impact of the COVID-19 Outbreak on the Sector | PR Newswire | 6/16/2020

… Abcam Adaptive Biotechnologies Aethlon Medical Agena Bioscience Angle plc Apocell ARUP Laboratories Beckman Coulter Becton Dickinson Bioarray Genetics BioCartis Biocept Biodesix Inc BioFluidica BioGenex bioMrieux Bio-Rad Bio-Techne Bristol- Myers Squibb Cancer Genetics Caris … Genetics/Myriad RBM Nanostring Natera Neogenomics New Oncology Oncocyte Ortho Clinical Diagnostics Perkin Elmer Personal Genome Diagnostics Pfizer Promega Protagen Diagnostics Qiagen Quanterix Rarecells SAS Roche Diagnostics Siemens Silicon Biosystems SkylineDx SRI International Sysmex Thermo …

Biocept

World Immuno-Oncology Diagnostics Market Forecasts to 2024 and the Impact of the COVID-19 Outbreak on the Sector | PR Newswire | 6/16/2020

… Laboratories Abcam Adaptive Biotechnologies Aethlon Medical Agena Bioscience Angle plc Apocell ARUP Laboratories Beckman Coulter Becton Dickinson Bioarray Genetics BioCartis Biocept Biodesix Inc BioFluidica BioGenex bioMrieux Bio-Rad Bio-Techne Bristol- Myers Squibb Cancer Genetics … Genetics/Myriad RBM Nanostring Natera Neogenomics New Oncology Oncocyte Ortho Clinical Diagnostics Perkin Elmer Personal Genome Diagnostics Pfizer Promega Protagen Diagnostics Qiagen Quanterix Rarecells SAS Roche Diagnostics Siemens Silicon Biosystems SkylineDx SRI International Sysmex Thermo …

The Carlyle Group

Ortho Announces Board of Director Appointments | PR Newswire | 9/1/2020

… as an Independent Director Chris Smith Appointed Chairman of the Board, in addition to current CEO role RARITAN, N.J. Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that David B. Perez … Steve Wise , Managing Director and Global Head of Healthcare for The Carlyle Group. “On behalf of the Board, we also want to sincerely thank Robert for his service as Chairman. Robert skillfully led Ortho through …

Visiongain Report Claims there is Huge Potential Within the $34bn Immunochemistry Reagents, Analyzers and Test Kits Market | PR Newswire | 11/13/2019

… Analyzers Market . • Profiles and generic drugs revenue forecasts from 2019-2029 of these selected leading companies: • Abbott • bioMerieux • Danaher • Fujirebio • Ortho Clinical Diagnostics • Roche • Siemens • Sysmex Corporation • Thermo Fisher Scientific • Trivitron Healthcare Pvt. Ltd. • Qualitative analysis … Price Waterhouse Coopers (PWC) Pronota Qualigen Roche Royal Philips Electronics The Carlyle Group Shenzhen Mindray Bio-Medical Electronics Co Siemens Siemens Healthcare Sigma- Aldrich Span Diagnostics State Food and Drug Administration Substance Abuse and Mental …

Carlyle Group

Ortho Announces Board of Director Appointments | PR Newswire | 9/1/2020

… as an Independent Director Chris Smith Appointed Chairman of the Board, in addition to current CEO role RARITAN, N.J. Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that David B. Perez … Wise , Managing Director and Global Head of Healthcare for The Carlyle Group. “On behalf of the Board, we also want to sincerely thank Robert for his service as Chairman. Robert skillfully led Ortho through a …

Ortho Clinical Diagnostics Names Joseph M. Busky Chief Financial Officer | PR Newswire | 7/6/2020

RARITAN, N.J. Ortho Clinical Diagnostics, a global leader of in vitro diagnostics backed by The Carlyle Group, announced Joseph M. Busky has joined the Company as Chief Financial Officer, effective July 7, 2020 . Busky, who previously served as Chief Financial Officer for Vyaire Medical, Inc., has over 30 years of experience in corporate and operational finance for large, global companies across diagnostics, medical devices, telecom, and marketing services. “Joe has …

Foresite Capital

DNAnexus raises $100M for a cloud-based analytics platform aimed at genomics and other clinical big data | TechCrunch | 6/9/2020

… specialist science and biotech investors), with participation also from previous backers GV (which has been around since almost the beginning), Foresite Capital, TPG Capital and First Round Capital. DNAnexus is also picking up a new … the platform is used by eight of the top 10 clinical diagnostics companies and seven of the world’s biggest pharmaceutical companies, which use 10 million core processing hours each month and store 28 petabytes of …

VC-backed Adaptive goes public | PE Hub | 6/27/2019

… Morgan and BofA Merrill Lynch are the lead underwriters. Adaptive’s pre-IPO backers include Viking Global Matrix Capital Management Celgene, Foresite Capital and Alexandria Venture Investments. PRESS RELEASE SEATTLE, June 26, 2019 (GLOBE NEWSWIRE) — Adaptive … precision and speed to develop products in life sciences research, clinical diagnostics, and drug discovery. We have two commercial products, and a robust clinical pipeline to diagnose, monitor and enable the treatment of diseases such …

Perceptive Advisors

DNAnexus raises $100 million to expand its genomics data analysis platform | VentureBeat | 6/9/2020

Perceptive Advisors and Northpond Ventures. DNAnexus says the funds will advance its international growth, enabling the company to serve health care and life science organizations around the world as it grows its cloud-based clinical testing offerings. A number of DNAnexus customers — which include eight of the top 10 clinical diagnostics companies, seven of the top 10 pharmaceutical companies, and over 100 enterprises — tap the platform for machine learning applications …

DNAnexus raises $100M for a cloud-based analytics platform aimed at genomics and other clinical big data | TechCrunch | 6/9/2020

… school of medicine, has raised $100 million in funding. The round, technically a Series G, is being co-led by Perceptive Advisors and Northpond Ventures (both specialist science and biotech investors), with participation also from … the platform is used by eight of the top 10 clinical diagnostics companies and seven of the world’s biggest pharmaceutical companies, which use 10 million core processing hours each month and store 28 petabytes of …

Goldman Sachs

Visiongain Report Claims there is Huge Potential Within the $34bn Immunochemistry Reagents, Analyzers and Test Kits Market | PR Newswire | 11/13/2019

… Analyzers Market . • Profiles and generic drugs revenue forecasts from 2019-2029 of these selected leading companies: • Abbott • bioMerieux • Danaher • Fujirebio • Ortho Clinical Diagnostics • Roche • Siemens • Sysmex Corporation • Thermo Fisher Scientific • Trivitron Healthcare Pvt. Ltd. • Qualitative analysis … and Drug Administration (FDA) US Fujirebio Diagnostics Gifu University Gimv Goldman Sachs Health Protection Agency (HPA) Hycor-Agilent Inova Diagnostics Iris Healthcare Italian National Health Service J Mitra & Co Johnson & Johnson Lilac Medicare Lyon Civil …

Adaptive Biotechnologies IPO: Five things to know - MarketWatch | 6/27/2019

Adaptive Biotechnologies Corp., a life-sciences research and clinical diagnostics company that says data from the immune system is the key to diagnosing and treating diseases, is planning to go public. The company ADPT, +0.00 … under the symbol ADPT. The underwriters on the deal are Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Cowen, Guggenheim Securities, William Blair and BTIG. Adaptive is putting together a massive database of hard-to-obtain …

Illumina Ventures

Novel Cell Sorting and Separation Markets, 2030 | PR Newswire | 10/7/2019

… analysis to estimate the likely demand for novel cell sorting products and solutions across key application areas, including research studies, clinical diagnostics, cell-based therapeutics, and other applications, in different global regions for the period … Lifesciences Icahn School of Medicine ICE Angels iCellate ICREA Ignyta Illumina Ventures IMEC immatics biotechnologies Immunomedics ImmunoQure Inabata Inbiomotion IncellDx IncoCell Tianjin Incyte Inguran Innate Pharma Innovate UK Innovative Biochips Innovative Micro Technology Inova Institute …

Illumina Ventures Closes $230 Million Fund | PR Newswire | 10/16/2017

Worldwide Offices Illumina Ventures Closes $230 Million Fund Genomics-focused fund will support breakthroughs in life science research, clinical diagnostics, novel therapeutic platforms, and other technologies impacting human health News provided by 07:00 ET Share this article SAN FRANCISCO , Oct. 16, Illumina Ventures, an independent, early-stage venture capital firm, announced today that it has raised $230 million for its first fund. Illumina Ventures was launched in the summer of …

Merrill Lynch

VC-backed Adaptive goes public | PE Hub | 6/27/2019

… stock began trading June 27, 2019 on the NASDAQ under the ticker symbol “ADPT.” Goldman Sachs, J.P. Morgan and BofA Merrill Lynch are the lead underwriters. Adaptive’s pre-IPO backers include Viking Global Matrix Capital … precision and speed to develop products in life sciences research, clinical diagnostics, and drug discovery. We have two commercial products, and a robust clinical pipeline to diagnose, monitor and enable the treatment of diseases such …

Vertex Pharmaceuticals Incorporated (VRTX) CEO Jeff Leiden on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/1/2019

… Conference Call Participants Geoff Meacham - Barclays Phil Nadeau - Cowen & Company Michael Yee - Jefferies Alethia Young - Cantor Fitzgerald Ying Huang - BoA Merrill Lynch Geoffrey Porges - SVB Leerink Brian Abrahams - RBC Capital Markets Cory Kasimov - JPMorgan Paul … our new Chief Financial Officer. Charlie joins us from Ortho-Clinical Diagnostics, where he served as CFO and Executive Vice President of Finance. Charlie has served as CFO for public and private companies for more …

Mayo Clinic

Readers and Tweeters Grapple With COVID Therapies and Forecasts | Kaiser Health News | 9/14/2020

… on the safety and efficacy of convalescent plasma before issuing Emergency Use Authorization (EUA). The agency also pointed to a Mayo Clinic preliminary analysis of 56,000 patients who were given high or low titer units … as Global Head of Medical and Scientific Affairs at Ortho Clinical Diagnostics, Raritan, New Jersey /em /p blockquote p I’m quoted here saying what everybody already knows: if we want to know if plasma works …

Readers and Tweeters Grapple With COVID Therapies and Forecasts | Kaiser Health News | 9/14/2020

… on the safety and efficacy of convalescent plasma before issuing Emergency Use Authorization (EUA). The agency also pointed to a Mayo Clinic preliminary analysis of 56,000 patients who were given high or low titer units … as Global Head of Medical and Scientific Affairs at Ortho Clinical Diagnostics, Raritan, New Jersey /em /p blockquote p I’m quoted here saying what everybody already knows: if we want to know if plasma works …

Mount Sinai Health System

Bio-Techne And Kantaro Biosciences Announce Partnership To Develop And Scale Production Of COVID-19 Serology Test | PR Newswire | 5/19/2020

MINNEAPOLIS and NEW YORK , May 19, Bio-Techne Corporation (NASDAQ: TECH ) and the Mount Sinai Health System in New York , through its commercial affiliate Kantaro Biosciences LLC (Kantaro), today announced a partnership to initiate scaled manufacturing and distribution of testing kits based on the Mount Sinai -developed COVID-19 serology test. Kantaro Biosciences is a joint venture between Mount Sinai Health System (“ Mount Sinai “) and Renalytix AI (LSE: RENX) formed …

Technopath Clinical Diagnostics Expands Its Portfolio of Third-party Quality Control Solutions for COVID-19 as Clinical Laboratories Globally Ramp Up Antibody Testing | Yahoo News | 5/11/2020

CNW Group May 11, 2020, 6:00 a.m. UTC NEW YORK and BALLINA, Ireland , May 11, 2020 /CNW/ – Technopath Clinical Diagnostics today launched its Multichem ID-COVID-19 Quality Control Solutions offering laboratories third-party quality … Abbott, Roche, Ortho Clinical Diagnostics, Cellex, Chembio Diagnostic Systems, the Mount Sinai Health System, Autobio and DiaSorin. “With antibody testing accelerating across nations, clinical laboratories should be demanding data on validation studies, sensitivity and specificity …

Sinai Health System

Bio-Techne And Kantaro Biosciences Announce Partnership To Develop And Scale Production Of COVID-19 Serology Test | PR Newswire | 5/19/2020

MINNEAPOLIS and NEW YORK , May 19, Bio-Techne Corporation (NASDAQ: TECH ) and the Mount Sinai Health System in New York , through its commercial affiliate Kantaro Biosciences LLC (Kantaro), today announced a partnership to initiate scaled manufacturing and distribution of testing kits based on the Mount Sinai -developed COVID-19 serology test. Kantaro Biosciences is a joint venture between Mount Sinai Health System (“ Mount Sinai “) and Renalytix AI (LSE: RENX) formed …

Technopath Clinical Diagnostics Expands Its Portfolio of Third-party Quality Control Solutions for COVID-19 as Clinical Laboratories Globally Ramp Up Antibody Testing | Yahoo News | 5/11/2020

CNW Group May 11, 2020, 6:00 a.m. UTC NEW YORK and BALLINA, Ireland , May 11, 2020 /CNW/ – Technopath Clinical Diagnostics today launched its Multichem ID-COVID-19 Quality Control Solutions offering laboratories third-party quality … Roche, Ortho Clinical Diagnostics, Cellex, Chembio Diagnostic Systems, the Mount Sinai Health System, Autobio and DiaSorin. “With antibody testing accelerating across nations, clinical laboratories should be demanding data on validation studies, sensitivity and specificity, and …

Northwell Health

Northwell Implements New On-site Laboratory Treatment Technology for COVID-19 Infected Medical Waste | Business Wire | 3/30/2020

LAKE SUCCESS, N.Y.- To minimize the risk of spreading COVID-19, Northwell Health has become the first US health system to implement a new technology that breaks down medical waste from laboratory testing in a safe, environmentally friendly way. Developed by Irish-based Technopath Clinical Diagnostics, the Envetec 200 system simultaneously shreds and disinfects infectious waste using a patented destruction and disinfection process that kills all COVID-19 viruses along …

Technopath’s Pioneering Technology for the Treatment of COVID-19 Infected Medical Waste Is Fast-tracked for Immediate Use at New York’s Largest Health Care Provider | PR Newswire | 3/30/2020

NEW YORK and BALLINA, Ireland , March 30, Technopath Clinical Diagnostics today announced that Northwell Health, New York State’s largest healthcare provider with 23 hospitals and nearly 800 outpatient facilities, is minimizing the risk of spreading COVID-19 by adopting Technopath’s technology platform that safely neutralizes infectious medical waste. Northwell is the first health system worldwide to implement Technopath’s pioneering technology. Envetec 200 system simultaneously shreds and disinfects infectious medical waste …

MD Anderson Cancer Center

Viracor Eurofins Expands Its Clinical Diagnostic Footprint to Oncology | PR Newswire | 12/11/2019

Clinical Diagnostics group. Dr. Eterovic will lead the development and growth of oncology clinical diagnostic solutions to benefit our healthcare clients and their patients. Dr. Eterovic joins us from MD Anderson Cancer Center, where she was Associate Professor and Director of the Cancer Genomics Laboratory, as well as a driving force in the implementation of precision medicine at the prestigious institute; establishing a genomics laboratory for their NGS (Next Generation …

Viracor Eurofins Expands Its Clinical Diagnostic Footprint to Oncology | Yahoo News | 12/11/2019

… span class=”xn-person” Karina Eterovic /span , PhD, as the Director of Research & Development for Oncology Diagnostics for Eurofins U.S. Clinical Diagnostics group. Dr. Eterovic will lead the development and growth of oncology clinical diagnostic … eurofins.com (PRNewsfoto/Viracor Eurofins) More Dr. Eterovic joins us from MD Anderson Cancer Center, where she was Associate Professor and Director of the Cancer Genomics Laboratory, as well as a driving force in the implementation …

Massachusetts General Hospital

MicroMedicine to Launch Automated, Microfluidics-based Cell Isolation Technology at the Society for Immunotherapy of Cancer (SITC) Meeting | PR Newswire | 11/5/2019

Massachusetts General Hospital in 2015 by prominent physicians and researchers, MicroMedicine is committed to transforming research, clinical diagnostics, and cell therapy with novel innovations. The patented microfluidic platform can be utilized for multiple applications, including cell isolation, cell concentration, and fluid exchange. The company is located in the heart of Boston’s life sciences ecosystem in Waltham, Massachusetts . For more information about MicroMedicine, Inc., please call 617-744-1918, visit micromedicine.com or https …

Global Genitourinary Partnering Deal Trends, Players and Financials Directory 2014-2019 | PR Newswire | 10/24/2019

… Jolla Pharmaceutical Lavasta Pharma LeMaitre Vascular Lupus Foundation of America (LFA) Luqa Pharmaceuticals Mannin Research Mar Cor Purification Mariel Therapeutics Massachusetts General Hospital Mayo Clinic MD Anderson Cancer Center MedCom MediBeacon MediGene Medinova Medipal Holdings … Pharmaceuticals Noventure Novo Nordisk Nxstage Medical OPKO Health Organovo Ortho-Clinical Diagnostics Otsuka Outpost Medicine Oxford Immunotec Palette Life Sciences Pansend Par Pharmaceutical Patheon N.V. Perlara Pfizer Phadia Pharmacological research Institute Mario Negri PharmaSwiss Pharmstandard …

Cleveland Clinic

Global Genitourinary Partnering Deal Trends, Players and Financials Directory 2014-2019 | PR Newswire | 10/24/2019

… Hospital Caldera Pharmaceuticals CamelBak Cara Therapeutics CARB-X Cardio Renal Society of America Casper Pharma Celtic Biotech ChemoCentryx CJ Corp Cleveland Clinic Clinipace Worldwide Codexis Cogentix Medical Collaborative Study Group Columbia University Control Flo Medical … Pharmaceuticals Noventure Novo Nordisk Nxstage Medical OPKO Health Organovo Ortho-Clinical Diagnostics Otsuka Outpost Medicine Oxford Immunotec Palette Life Sciences Pansend Par Pharmaceutical Patheon N.V. Perlara Pfizer Phadia Pharmacological research Institute Mario Negri PharmaSwiss Pharmstandard …

Study Published in Journal of Clinical Investigation Insight Demonstrates Ability to Predict Early Rejection in Kidney Transplant with FractalDx Portfolio Technology | PR Newswire | 6/7/2019

NEW YORK , June 7, Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announced today that positive study results have been published in the Journal of Clinical Investigation … Medicine, Mount Sinai Health System, University of Manatoba, Westmead Hospital, Cleveland Clinic, and University of Oxford. RenalytixAI intends to begin the clinical validation program for its acute transplant rejection diagnostic in H2 2019 and to …

Nassau University Medical Center

Dr. Chirag Parikh | 10/22/2019

NEW YORK, Oct. 14, 2019 /PRNewswire/ – Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announced today the appointment of leading kidney investigator and clinician Dr. Chirag Parikh … India and subsequently completed his internal medicine residency at the Nassau University Medical Center and SUNY at Stony Brook in New York, followed by his fellowship in Nephrology and Hypertension and UNOS Transplant Certification at …

Johns Hopkins Director of Nephrology Chirag Parikh Joins RenalytixAI Board | PR Newswire | 10/14/2019

NEW YORK Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announced today the appointment of leading kidney investigator and clinician Dr. Chirag Parikh to the Renalytix board … India and subsequently completed his internal medicine residency at the Nassau University Medical Center and SUNY at Stony Brook in New York , followed by his fellowship in Nephrology and Hypertension and UNOS Transplant Certification at …

Children's Hospital Los Angeles, Los Angeles CA

Luminex Corporation Receives FDA Clearance for ARIES Group A Strep Assay | PR Newswire | 10/31/2017

… it comes to dealing with infectious diseases,” said Dr. Jennifer Dien Bard , Director, Clinical Microbiology and Virology Laboratory at the Children’s Hospital Los Angeles. “Having tests that are easy to use and require only minimal … a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver …

Luminex Corporation Receives FDA Clearance for ARIES Group A Strep Assay | PR Newswire | 10/31/2017

… it comes to dealing with infectious diseases,” said Dr. Jennifer Dien Bard , Director, Clinical Microbiology and Virology Laboratory at the Children’s Hospital Los Angeles. “Having tests that are easy to use and require only minimal … a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver …

CDPHP

RenalytixAI Partners with Capital District Physicians’ Health Plan, Inc. on KidneyIntelX™ | PR Newswire | 10/17/2019

NEW YORK Renalytix AI plc (AIM: RENX), a developer of artificial intelligence enabled clinical diagnostics for kidney disease, announces that Capital District Physicians’ Health Plan, Inc. (CDPHP ® ), a physician led health insurance provider, has adopted coverage determination policies that will provide KidneyIntelX™ for qualified CDPHP members who have Type 2 diabetes and chronic kidney disease (diabetic kidney disease or “DKD”). In the United States , approximately 12 million people currently have …

RenalytixAI Partners with Capital District Physicians’ Health Plan, Inc. on KidneyIntelX™ | BioSpace | 10/17/2019

RenalytixAI Partners with Capital District Physicians’ Health Plan, Inc. on KidneyIntelX™ Published: Oct 17, 2019 Effective October 16, KidneyIntelX will be covered for reimbursement for qualified members NEW YORK , Oct. 17, 2019 /PRNewswire/ – Renalytix AI plc (AIM: RENX), a developer of artificial intelligence enabled clinical diagnostics for kidney disease, announces that Capital District Physicians’ Health Plan, Inc. (CDPHP ® ), a physician led health insurance provider, has adopted coverage determination policies that …

Robert Yates

Ortho Announces Board of Director Appointments | PR Newswire | 9/1/2020

… as an Independent Director Chris Smith Appointed Chairman of the Board, in addition to current CEO role RARITAN, N.J. Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that David B. Perez … joined Ortho in September 2019 as Chief Executive Officer, succeeds Robert Yates , who has served as Ortho’s Chairman since February 2019 . Yates will continue to serve as a member of the Board of Directors. “It …

Chris Smith

Ortho Announces Board of Director Appointments | PR Newswire | 9/1/2020

Noted Diagnostic Industry Veteran David B. Perez Joins as an Independent Director Chris Smith Appointed Chairman of the Board, in addition to current CEO role RARITAN, N.J. Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that David B. Perez , an accomplished global medical device industry veteran, has been appointed as an independent member to its Board of Directors. Perez is the former president and CEO of …

Craig Overpeck

Ortho Care™ Again Ranks No. 1 for Service in Diagnostics Industry | PR Newswire | 7/21/2020

PRNewswire/ – Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a worldwide reputation for top-rated customer service and support, today announced that its Ortho Care™ holistic service and support program was ranked … wins top awards in all categories, year after year,” said Craig Overpeck , chief executive officer, IMV. “This is an amazing achievement, which is reflective of Ortho’s high level of customer satisfaction. Ortho should be extremely …

Robin Smith

Orig3n Announces Comprehensive Solution To Provide COVID-19 Testing For Boarding Schools | PR Newswire | 6/23/2020

BOSTON Orig3n, Inc., a Boston -based company pioneering the future of wellness and health through diagnostics, genetics and biotechnology, has announced a comprehensive solution to provide COVID-19 testing for boarding schools. Orig3n is offering the Orig3n 2019 Novel Coronavirus (COVID-19) Test under an Emergency Use Authorization (EUA) from FDA to authorized healthcare providers and institutions nationwide. The test detects the presence of nucleic acid from the virus that …

Laura Wood

Global Market Outlook for the Coronavirus Diagnostics Market to 2027 | PR Newswire | 6/19/2020

… Coronavirus Diagnostics Market include Abbott, Beckman Coulter , Becton, Dickinson and Company, bioMerieux, Bio-Rad Laboratories, GSK Biologicals, Hologic, Lonza, Ortho-Clinical Diagnostics, PerkinElmer, Qiagen and Roche Diagnostics. What the report offers: Market share assessments for … focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood , Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 …

Graham Mullis

Novacyt shares jump after launch of new COVID-19 testing products | Yahoo News | 6/18/2020

By Sudip Kar-Gupta PARIS (Reuters) - Healthcare and clinical diagnostics company Novacyt ALNOV.PA NCYT.L , whose shares have surged on the back of its COVID-19 testing products, on Thursday announced the launch of three new … further support through the launch of these new products,” CEO Graham Mullis said. Novacyt has singled itself out with a test able to detect the new coronavirus in less than two hours. Standard testing, which …

Scott Becker

These Labs Rushed to Test for Coronavirus. They Had Few Takers. | Yahoo News | 5/21/2020

… testing response in a public health crisis, there is, in fact, little coordination among public and private health labs, said Scott Becker, chief executive of the Association of Public Health Laboratories, an association of state … University of California, San Diego and the for-profit Eurofins Clinical Diagnostics, said they were surprised when they heeded the call to scale up testing in March but were not sent as many samples as …

Christopher Hill

Ortho’s COVID-19 IgG Antibody Test Receives CE Mark | PR Newswire | 5/18/2020

… to run - Ortho has already begun shipping its antibody test to customers in highly impacted geographies and plans to manufacture several million COVID-19 antibody tests each month RARITAN, N.J. , May 18, Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a rich history of bringing critical tests for infectious diseases to market, today announced its second COVID-19 antibody test—the VITROS ® Immunodiagnostic Products Anti-SARS-CoV …

Chuck Kummeth

Bio-Techne Releases Third Quarter Fiscal 2020 Results | PR Newswire | 4/30/2020

… indicative of the resolve and energy our teams around the world have to succeed in these trying times. I want to thank all of our employees for their commitment and hard work,” said Chuck Kummeth , President and Chief Executive Officer of Bio-Techne. “A finish of 6% organic growth is a great accomplishment for the company, given the unprecedented challenges we all faced with the COVID-19 virus pandemic during …

Donald Trump

Live updates on COVID-19: March 16-31 | Modern Healthcare | 4/24/2020

… American Hospital Association wants HHS to immediately send billions of dollars to hospitals under the stimulus package signed by President Donald Trump last week. The department should direct Medicare Administrative Contractors “distribute funds to every … Northwell is using a system from Irish biotechnology company Technopath Clinical Diagnostics that shreds and disinfects infectious waste, killing bacteria, spores and pathogens. The resulting waste—which Northwell describes as “confetti-like” in a news …

Andrew Cuomo

Mount Sinai gets OK to do antibody testing | Crain’s New York Business | 4/21/2020

… to fight off the virus that causes Covid-19. Testing for this type of immunity has been identified by Gov. Andrew Cuomo as key to reopening the state’s economy and lifting restrictions on social interaction … granted emergency authorization by the FDA. They are Cellex, Ortho Clinical Diagnostics and Chembio Diagnostic Systems. The New York Times reported that some antibody tests on the market have inaccurately identified people as having antibodies …

Carlos Cordon-Cardo

Mount Sinai gets OK to do antibody testing | Crain’s New York Business | 4/21/2020

… and the need to connect to more commercial lab partners that can increase the number of tests conducted, said Dr. Carlos Cordon-Cardo, Mount Sinai’s chair of pathology. He predicted that Mount Sinai would be … granted emergency authorization by the FDA. They are Cellex, Ortho Clinical Diagnostics and Chembio Diagnostic Systems. The New York Times reported that some antibody tests on the market have inaccurately identified people as having antibodies …

Barbara Zucker

Technopath’s Pioneering Technology for the Treatment of COVID-19 Infected Medical Waste Is Fast-tracked for Immediate Use at New York’s Largest Health Care Provider | PR Newswire | 3/30/2020

NEW YORK and BALLINA, Ireland , March 30, 2020 /PRNewswire/ – Technopath Clinical Diagnostics today announced that Northwell Health, New York State’s largest healthcare provider with 23 hospitals and nearly 800 outpatient facilities, is minimizing the risk … next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra /Northwell and the Hofstra Northwell School of Graduate Nursing and Physician Assistant Studies. For information on our more …

Michael Dowling

Technopath’s Pioneering Technology for the Treatment of COVID-19 Infected Medical Waste Is Fast-tracked for Immediate Use at New York’s Largest Health Care Provider | PR Newswire | 3/30/2020

NEW YORK and BALLINA, Ireland , March 30, 2020 /PRNewswire/ – Technopath Clinical Diagnostics today announced that Northwell Health, New York State’s largest healthcare provider with 23 hospitals and nearly 800 outpatient facilities, is minimizing the risk … the health and safety challenges posed by COVID-19,” said Michael Dowling , Northwell president and CEO. “This new technology allows us to remove the unknown risk exposure when disposing of medical waste while avoiding the …

Dwayne Breining

Northwell Implements New On-site Laboratory Treatment Technology for COVID-19 Infected Medical Waste | Business Wire | 3/30/2020

… technology that breaks down medical waste from laboratory testing in a safe, environmentally friendly way. Developed by Irish-based Technopath Clinical Diagnostics, the Envetec 200 system simultaneously shreds and disinfects infectious waste using a patented … the very latest and innovative technologies available in healthcare,” said Dwayne Breining, MD , executive director of Northwell Labs. “We have carefully evaluated our options to eliminate any potential risks associated with the new large-scale …

Chad Robins

Adaptive Biotechnologies and Microsoft expand partnership to decode COVID-19 immune response and provide open data access | PR Newswire | 3/20/2020

… to the virus and the disease patterns that can be inferred from studying these data at the population level,” said Chad Robins , CEO and co-founder of Adaptive Biotechnologies. “Immune response data may enable detection … precision and speed to develop products in life sciences research, clinical diagnostics, and drug discovery. We have two commercial products, and a robust clinical pipeline to diagnose, monitor and enable the treatment of diseases such …

Sarah Smith

Polymerase Chain Reaction (PCR) Global Market - Forecast to 2025 | PR Newswire | 11/7/2019

… testing, technological advancements and growing demand for rapid diagnostic tests. However, factors like high cost of commercial PCR assays in clinical diagnostics, lack of awareness and requirement of skilled labor, development of alternate technologies and … all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +1 (718) 213 4904 Website: www.reportbuyer.com SOURCE ReportBuyer Related Links http://www.reportbuyer.com …

Jack Meehan

Bio Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/1/2019

Bio Rad Laboratories, Inc. (NYSE: BIO ) Q3 2019 Earnings Conference Call October 31, 2019 5:00 PM ET Company Participants Ronald Hutton - VP & Treasurer Ilan Daskal - EVP & CFO Norman Schwartz - Chairman, CEO & President Andrew Last - EVP & COO Annette Tumolo - EVP & President, Life Science Group John Hertia - EVP & President, Clinical Diagnostics Group Conference Call Participants Brandon Couillard - Jefferies Jack Meehan - Barclays Bank Operator Ladies and gentlemen, thank you for standing by, and …

Brandon Couillard

Bio Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/1/2019

Bio Rad Laboratories, Inc. (NYSE: BIO ) Q3 2019 Earnings Conference Call October 31, 2019 5:00 PM ET Company Participants Ronald Hutton - VP & Treasurer Ilan Daskal - EVP & CFO Norman Schwartz - Chairman, CEO & President Andrew Last - EVP & COO Annette Tumolo - EVP & President, Life Science Group John Hertia - EVP & President, Clinical Diagnostics Group Conference Call Participants Brandon Couillard - Jefferies Jack Meehan - Barclays Bank Operator Ladies and gentlemen, thank you for standing by, and …

Gilles Martin

Eurofins Reports Strong Organic Growth (over 6%) in Q3 2019 | Business Wire | 10/28/2019

… efforts to determine and agree on exact damages will be on going for a while. Comment from the CEO, Dr. Gilles Martin: “Q3 2019 was a very positive quarter for Eurofins as the Group demonstrated … with a range of superior new product launches. In France, Clinical Diagnostics continued to perform in line with management’s expectations with a positive organic growth even if below Group average. In North America, Eurofins’ BioPharma …

Mark Calarco

National Prescription Drug Take Back Day will accept vapes, cartridges for the first time | Yahoo News | 10/26/2019

Mark Calarco , the national medical director for clinical diagnostics at American Addiction Centers , tells Yahoo Lifestyle: “While we will have to wait to see if this new initiative is actually effective, it does send a powerful message that vaping is not inherently safe and people may need to take action to protect their health. In light of the recent deaths and health consequences linked to vaping, this is a step …

Hans Cobben

BlueBee Establishes Data Center in Mainland China, Expanding Global Coverage for Its Genomics Data Platform | PR Newswire | 10/9/2019

… globe. “We were drawn to setting up our mainland China data center to meet the demands of partner clients,” says Hans Cobben , CEO BlueBee. “Serving the global community remains at the helm of our mandate … medical devices. BlueBee serves molecular assay and service providers in clinical diagnostics, therapeutics, and research with a shared mission—to power precision medicine. BlueBee software solutions are available for deployment globally, including most recently—mainland …

Andrew Morris

SQI Diagnostics Reports Third Quarter 2019 Results | PR Newswire | 8/28/2019

… Toronto -based life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced multiplexed diagnostics. Said Andrew Morris , SQI’s President and CEO: “During the last quarter we achieved a significant milestone … its automated instrumentation for the pharmaceutical research, animal health, and clinical diagnostics markets. SQI develops custom research and diagnostic assays that are multiplexed; meaning the simplification, consolidation and automation of many individual tests into one …

Patrick Donnelly

Bio Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 8/2/2019

Bio Rad Laboratories (NYSE: BIO ) Q2 2019 Earnings Conference Call August 1, 2019 5:00 PM ET Company Participants Ronald Hutton - VP & Treasurer Ilan Daskal - EVP & CFO Norman Schwartz - Chairman, CEO & President Andrew Last - EVP & COO Annette Tumolo - EVP & President of Life Science Group John Hertia - EVP & President, Clinical Diagnostics Group Conference Call Participants Patrick Donnelly - Goldman Sachs Group Mitchell Petersen - Barclays Bank Daniel Leonard - Deutsche Bank Brandon Couillard - Jefferies Operator …

Carl O'Donnell

Exclusive: Carlyle explores sale or IPO of Ortho-Clinical Diagnostics - sources | Reuters | 11/10/2017

November 10, 2017 / 6:09 AM / Updated 8 hours ago Exclusive: Carlyle explores sale or IPO of Ortho-Clinical Diagnostics - sources Greg Roumeliotis , Carl O’Donnell 3 Min Read (Reuters) - Private equity firm Carlyle Group LP is exploring a sale or initial public offering of Ortho-Clinical Diagnostics Inc, a U.S. diagnostics company that could be valued at more than $7 billion, including debt, people familiar with the matter said. FILE PHOTO …

New York, New York

Global Serological Transplant Diagnostics Industry | Globe Newswire | 9/23/2020

New York, Reportlinker.com announces the release of the report “Global Serological Transplant Diagnostics Industry” - https://www.reportlinker.com/p05960007/?utm_source=GNW 4 Million by 2027, growing at aCAGR of 2.6% over the period 2020-2027. Reagents & Accessories … Boy S.A.S. Lorne Laboratories Ltd. MTC med. Produkte GmbH Ortho Clinical Diagnostics Quotient Biodiagnostics REAGENS Kft. Siemens Healthineers Thermo Fisher Scientific, Inc. Tulip Ltd. Read the full report: https://www.reportlinker.com/p05960007/?utm_source=GNW I …

State of New York

Global Serological Transplant Diagnostics Industry | Globe Newswire | 9/23/2020

New York, Reportlinker.com announces the release of the report “Global Serological Transplant Diagnostics Industry” - https://www.reportlinker.com/p05960007/?utm_source=GNW 4 Million by 2027, growing at aCAGR of 2.6% over the period 2020-2027. Reagents & Accessories … Boy S.A.S. Lorne Laboratories Ltd. MTC med. Produkte GmbH Ortho Clinical Diagnostics Quotient Biodiagnostics REAGENS Kft. Siemens Healthineers Thermo Fisher Scientific, Inc. Tulip Ltd. Read the full report: https://www.reportlinker.com/p05960007/?utm_source=GNW I …

York, Pennsylvania

Global Serological Transplant Diagnostics Industry | Globe Newswire | 9/23/2020

New York, Reportlinker.com announces the release of the report “Global Serological Transplant Diagnostics Industry” - https://www.reportlinker.com/p05960007/?utm_source=GNW 4 Million by 2027, growing at aCAGR of 2.6% over the period 2020-2027. Reagents & Accessories … Boy S.A.S. Lorne Laboratories Ltd. MTC med. Produkte GmbH Ortho Clinical Diagnostics Quotient Biodiagnostics REAGENS Kft. Siemens Healthineers Thermo Fisher Scientific, Inc. Tulip Ltd. Read the full report: https://www.reportlinker.com/p05960007/?utm_source=GNW I …

State of Texas

National coronavirus updates: US death toll represents a quarter of the world’s total | 4/25/2020

… electronics factory in Kokomo, Indiana, working on shields and ventilators. About 60 Toyota workers are making protective equipment in Kentucky, Texas, Michigan and Alabama.Most automakers in the U.S. temporarily stopped making vehicles about a month … a test’s benefits could outweigh any risks.Three companies – DiaSorin, Ortho-Clinical Diagnostics and Autobio Diagnostics – received the authorizations. The tests were restricted to use in authorized laboratories, and the FDA cautioned that all three came …

State of Georgia

National coronavirus updates: US death toll represents a quarter of the world’s total | 4/25/2020

… toll has surpassed 53,000 people, according to Hopkins.Globally, there have been more than 2.8 million cases with more than 202,000 deaths.Georgia state officials are moving ahead with plans to allow some nonessential businesses to reopen … a test’s benefits could outweigh any risks.Three companies – DiaSorin, Ortho-Clinical Diagnostics and Autobio Diagnostics – received the authorizations. The tests were restricted to use in authorized laboratories, and the FDA cautioned that all three came …

State of Florida

Inspirata and Flagship Biosciences Announce New Technical Partnership and Integration at Pathology Visions 2020 | 10/27/2020

Tampa, Florida / Westminster, Colorado, Oct. 27, 2020 (GLOBE NEWSWIRE) — Cancer informatics and digital pathology provider Inspirata announced today a new technical partnership with clinical diagnostics service provider, Flagship Biosciences. The new partnership provides clinicians with digital access to TissueInsight™, an AI-based analysis engine for Send-Out tests like PD-L1. Working together, Flagship Bioscience’s TissueInsight and Inspirata’s Dynamyx solutions offer significant advantages over shipping physical samples. Inspirata’s Dynamyx affords …

State of Alaska

National coronavirus updates: US death toll represents a quarter of the world’s total | 4/25/2020

… authorizations, a lower regulatory standard used when the FDA believes a test’s benefits could outweigh any risks.Three companies – DiaSorin, Ortho-Clinical Diagnostics and Autobio Diagnostics – received the authorizations. The tests were restricted to use in … businesses reluctant to reopen. The states of Georgia, Oklahoma and Alaska started loosening restrictions on businesses despite warnings from experts that such steps might be coming too soon. Some owners said they weren’t yet ready …

State of Michigan

National coronavirus updates: US death toll represents a quarter of the world’s total | 4/25/2020

… factory in Kokomo, Indiana, working on shields and ventilators. About 60 Toyota workers are making protective equipment in Kentucky, Texas, Michigan and Alabama.Most automakers in the U.S. temporarily stopped making vehicles about a month ago … a test’s benefits could outweigh any risks.Three companies – DiaSorin, Ortho-Clinical Diagnostics and Autobio Diagnostics – received the authorizations. The tests were restricted to use in authorized laboratories, and the FDA cautioned that all three came …

Detroit, Michigan

National coronavirus updates: US death toll represents a quarter of the world’s total | 4/25/2020

… hand sanitizer, which early in the crisis were in short supply.At Ford, over 800 people returned to work at four Detroit-area sites. General Motors has about 400 at a now-closed transmission plant in … a test’s benefits could outweigh any risks.Three companies – DiaSorin, Ortho-Clinical Diagnostics and Autobio Diagnostics – received the authorizations. The tests were restricted to use in authorized laboratories, and the FDA cautioned that all three came …

Atlanta, Georgia

National coronavirus updates: US death toll represents a quarter of the world’s total | 4/25/2020

… authorizations, a lower regulatory standard used when the FDA believes a test’s benefits could outweigh any risks.Three companies – DiaSorin, Ortho-Clinical Diagnostics and Autobio Diagnostics – received the authorizations. The tests were restricted to use in … Georgia governor’s announcement that he would not be reopening his Atlanta gym right away. “I feel like if we do this too soon, we’ll see a spike in cases and we’re back to square one …

Kokomo, Indiana

National coronavirus updates: US death toll represents a quarter of the world’s total | 4/25/2020

… sites. General Motors has about 400 at a now-closed transmission plant in suburban Detroit and an electronics factory in Kokomo, Indiana, working on shields and ventilators. About 60 Toyota workers are making protective equipment … a test’s benefits could outweigh any risks.Three companies – DiaSorin, Ortho-Clinical Diagnostics and Autobio Diagnostics – received the authorizations. The tests were restricted to use in authorized laboratories, and the FDA cautioned that all three came …

State of Indiana

National coronavirus updates: US death toll represents a quarter of the world’s total | 4/25/2020

… General Motors has about 400 at a now-closed transmission plant in suburban Detroit and an electronics factory in Kokomo, Indiana, working on shields and ventilators. About 60 Toyota workers are making protective equipment in … a test’s benefits could outweigh any risks.Three companies – DiaSorin, Ortho-Clinical Diagnostics and Autobio Diagnostics – received the authorizations. The tests were restricted to use in authorized laboratories, and the FDA cautioned that all three came …

State of Kentucky

National coronavirus updates: US death toll represents a quarter of the world’s total | 4/25/2020

… an electronics factory in Kokomo, Indiana, working on shields and ventilators. About 60 Toyota workers are making protective equipment in Kentucky, Texas, Michigan and Alabama.Most automakers in the U.S. temporarily stopped making vehicles about a … a test’s benefits could outweigh any risks.Three companies – DiaSorin, Ortho-Clinical Diagnostics and Autobio Diagnostics – received the authorizations. The tests were restricted to use in authorized laboratories, and the FDA cautioned that all three came …

State of Oklahoma

National coronavirus updates: US death toll represents a quarter of the world’s total | 4/25/2020

… authorizations, a lower regulatory standard used when the FDA believes a test’s benefits could outweigh any risks.Three companies – DiaSorin, Ortho-Clinical Diagnostics and Autobio Diagnostics – received the authorizations. The tests were restricted to use in … pandemic-wounded businesses reluctant to reopen. The states of Georgia, Oklahoma and Alaska started loosening restrictions on businesses despite warnings from experts that such steps might be coming too soon. Some owners said they weren’t …

State of Washington

COVID-19 antibody tests are raising as many questions as they answer | 5/28/2020

… be trusted. Yet the tests are getting better, says Alex Greninger, a virologist and diagnostics expert at the University of Washington. Months after allowing antibody tests into the market without regulatory vetting, the US Food … of their assay, using different antigens. For example, when Ortho Clinical Diagnostics developed its assay, Chockalingam Palaniappan, the company’s chief innovation officer, says it tested the nucleocapsid, the spike protein, and the SARS-CoV-2 …

State of California

Global Transplantation Industry | Globe Newswire | 9/22/2020

Clinical Diagnostics Oxford Immunotec Global PLC Pacific Biosciences of California, Inc. Pandorum Technologies Pvt. Ltd. Qiagen NV Siemens Healthineers SynCardia Thermo Fisher Scientific, Inc. Transplant Biomedicals S.L. XVIVO Perfusion AB Read the full report: https://www.reportlinker.com/p05960330/?utm_source=GNW I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Global Competitor Market Shares Transplantation Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of Covid-19 and a …

Boston, Massachusetts

Orig3n Announces Comprehensive Solution To Provide COVID-19 Testing For Boarding Schools | PR Newswire | 6/23/2020

BOSTON Orig3n, Inc., a Boston -based company pioneering the future of wellness and health through diagnostics, genetics and biotechnology, has announced a comprehensive solution to provide COVID-19 testing for boarding schools. Orig3n is offering the Orig3n 2019 Novel Coronavirus (COVID-19) Test under an Emergency Use Authorization (EUA) from FDA to authorized healthcare providers and institutions nationwide. The test detects the presence of nucleic acid from the virus that …

State of Tennessee

Eldermark Software Partners with Simply Connect to Enable Automated and Rapid COVID Lab Test Results | PRWeb | 6/24/2020

… Tennessee-based laboratory is a leading biotechnology firm committed to antimicrobial stewardship through high-complexity clinical diagnostics. “I’ve been operating in senior housing for nearly two decades and there’s always been an enormous need for automated lab test results,” said Eldermark CEO Craig Patnode. “The current process utilized by many can be a slow and inefficient slog through manual data entry and then waiting and waiting for receipt of results …

Washington, District of Columbia

CORONAVIRUS UPDATES: 1,329,799 infected, 79,528 deaths in U.S. | 5/11/2020

… that the Wuhan laboratory is “most likely” the source of the coronavirus outbreak based on “circumstantial evidence,” according to the Washington Times . “All other possible places of the virus’ origin have been proven to be … coronavirus antibody tests to determine immunity. Chembio Diagnostic Systems, Ortho Clinical Diagnostics, and Abbott Laboratories. Wednesday, April 15 The number of people infected with the coronavirus in the U.S. climbed to 609,685. The number of …

Los Angeles, California

COVID-19 Testing Provider Curative Acquires KorvaLabs | Globe Newswire | 5/19/2020

… continue to be produced and processed in KorvaLabs’ San Dimas, CA facilities May 19, 2020 10:00 ET Source: Curative Inc. LOS ANGELES, May 19, 2020 (GLOBE NEWSWIRE) – COVID-19 testing startup Curative Inc. announced today … more than 25 years of experience in biochemical analytics and clinical diagnostics. In addition to its CLIA certification, KorvaLabs has also been inspected and fully licensed by the California Department of Public Health and the …

Dublin, California

Global Molecular Diagnostics Market Analysis to 2022 - Molecular Diagnostics Take the Center Stage in COVID-19 Testing | Yahoo News | 6/17/2020

Dublin, June 17, 2020 (GLOBE NEWSWIRE) – The “Global Molecular Diagnostics Market - Technologies, Products, Applications and End-Use Sectors” report has been added to ResearchAndMarkets.com’s offering. Amid the COVID-19 outbreak, the global market for Molecular … Merck KGaA (Merck Millipore) Myriad Genetics, Inc. OriGene Technologies Ortho Clinical Diagnostics Oxford Gene Technology Pathogenetix, Inc. PerkinElmer, Inc. Promega Corporation Qiagen N.V. Savyon Diagnostics Seegene Inc. Shanghai Runda Medical Technology Co., Ltd. Siemens Healthcare …

State of South Carolina

Donating blood is an easy way to get a free, accurate COVID-19 antibody test | 5/29/2020

… only accurate 50 percent of the time. OneBlood, the not-for-profit blood center with locations in Florida, North Carolina, South Carolina, Georgia and Alabama, has been testing all blood donations for the COVID-19 … a Food and Drug Administration- approved test called the Ortho Clinical Diagnostics Vitros Anti-SARS-CoV2 Total Test, which has a specificity level of 100 percent. This is a good test to take according to …

State of Virginia

Coronavirus Roundup, May 23-May 29 | 5/29/2020

… used or tested for its effectiveness in Finland, Germany, the Netherlands, and by utilities in 42 U.S. states including Oregon, Virginia, Massachusetts, and Nevada, Begley reports. In the absence of widespread testing, this sewage testing … describes how specific tests, by Abbott, Roche, and by Ortho Clinical Diagnostics, are designed to operate biologically on the virus’s complex molecules (proteins). The story reports high accuracy rates for the Roche and Abbott antibody …

State of New Jersey

Ortho’s VITROS(R) B.R.A.H.M.S PCT Assay for Sepsis Now Available | 6/12/2020

RARITAN New Jersey–12 Jun–PRNewswire/InfoQuest Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, received CE Mark for its VITROS(R) B.R.A.H.M.S PCT (Procalcitonin) assay, now commercially available to help clinicians identify sepsis and other severe bacterial infections. Ortho’s newest assay is available on the VITROS(R) 3600 Immunodiagnostic System, the VITROS(R) 5600 and VITROS(R …

Norfolk, Virginia

CORONAVIRUS UPDATES: 1,329,799 infected, 79,528 deaths in U.S. | 5/11/2020

… since it docked in March to support the city’s hospitals in combating the coronavirus. The ship is now heading for Norfolk, Virginia where it will be prepared for its next deployment, in which the location … coronavirus antibody tests to determine immunity. Chembio Diagnostic Systems, Ortho Clinical Diagnostics, and Abbott Laboratories. Wednesday, April 15 The number of people infected with the coronavirus in the U.S. climbed to 609,685. The number of …